Raised Intracranial Pressure: Diagnosis and Management

Introduction

Raised intracranial pressure (ICP) is not itself a diagnosis but a final common pathway produced by many different neurological insults - haemorrhage, tumour, infection, hydrocephalus, or diffuse cerebral oedema. It matters because sustained elevation compromises cerebral perfusion and can force brain tissue to shift and herniate through rigid dural folds or the foramen magnum, which is rapidly fatal if not reversed.¹

Understanding raised ICP as a unifying concept - rather than memorising it separately for each cause - is what the Monro-Kellie doctrine provides, and it is one of the most elegant and testable pieces of physiology in clinical neurology.

Normal intracranial pressure in a supine adult is around 5-15 mmHg, with transient physiological rises during coughing, straining or sneezing that are of no consequence in a healthy brain. What matters clinically is not a single elevated reading but sustained elevation, typically taken as above 20-22 mmHg, and the duration for which it persists - since it is the product of pressure and time that determines secondary ischaemic injury.

The Monro-Kellie doctrine

The skull is a rigid, non-expansile container. Its contents - brain parenchyma (~80%), blood (~10%) and cerebrospinal fluid (~10%) - occupy a fixed total volume. The Monro-Kellie doctrine states that an increase in the volume of any one component must be offset by a decrease in one or both of the others, or intracranial pressure will rise.²

Initially, the brain compensates well: CSF is displaced into the spinal subarachnoid space and venous blood is displaced out of the skull, so pressure rises only modestly for a given increase in volume. Once these compensatory reserves are exhausted, however, the pressure-volume relationship becomes steep - a small further increase in volume produces a large rise in pressure. This explains why patients with a slowly growing mass lesion can remain asymptomatic for a long time and then deteriorate suddenly.

The practical consequence of this non-linear pressure-volume relationship is cerebral perfusion pressure (CPP), which is mean arterial pressure minus intracranial pressure. Because the brain has no significant energy reserve, perfusion must be maintained continuously; as ICP rises, CPP falls unless mean arterial pressure rises to compensate. This is exactly what Cushing's reflex achieves - a reflex surge in blood pressure to preserve cerebral perfusion, with the bradycardia arising secondarily from baroreceptor activation.

Understanding CPP explains two otherwise counterintuitive rules of management. First, hypotension is disastrous in a patient with raised ICP, because it collapses perfusion pressure from the other side of the equation - which is why aggressively lowering a raised blood pressure in a head-injured patient can cause harm. Second, treatments work by reducing one of the three intracranial compartments: osmotic agents shrink brain water, controlled ventilation reduces cerebral blood volume through vasoconstriction, and CSF drainage removes the third.

Aetiology

Clinical features

The classic triad of headache, vomiting and papilloedema reflects raised ICP itself, regardless of cause, though not all three are always present, particularly early on.

The reason the headache has this characteristic pattern is postural and physiological. Lying flat removes the gravitational assistance to cerebral venous drainage and raises intracranial pressure slightly; sleep-related hypoventilation raises PaCO2, causing cerebral vasodilatation and a further rise in intracranial blood volume. Both effects peak overnight, which is why the headache is worst on waking and improves after being upright for an hour or two.

The same physiology explains aggravation by coughing, sneezing or straining, all of which transiently raise intrathoracic pressure and impede venous return from the head. A patient who volunteers that their headache is worse when they bend forward or strain at stool is describing a mechanism, not a coincidence.

A practical caution concerns the reliability of GCS in isolation. Sedation, intoxication, dysphasia and pre-existing cognitive impairment all confound it, and a patient with an expressive dysphasia can score poorly on verbal response while being fully alert. Documenting the three components separately, rather than only the total, preserves the information that matters and makes deterioration easier to detect.

• Headache - characteristically worse in the morning, worse lying flat, and aggravated by coughing, straining or bending forward, all of which transiently raise intracranial venous pressure
• Vomiting - classically effortless and without preceding nausea ('projectile'), from direct pressure effects on the brainstem vomiting centre
• Papilloedema - swelling of the optic disc from impaired axoplasmic flow, visible on fundoscopy; can cause transient visual obscurations and, if prolonged, permanent visual field loss
• Reduced conscious level - from mild drowsiness to coma as pressure rises further
• Sixth nerve palsy - a false localising sign, since the long intracranial course of the abducens nerve makes it vulnerable to stretch from raised pressure regardless of where the underlying lesion is
• Seizures
• In infants - a bulging fontanelle and increasing head circumference, since open sutures allow the skull to expand

Herniation syndromes

As pressure rises and compensatory mechanisms fail, brain tissue can be forced across rigid anatomical boundaries - the falx cerebri, the tentorium cerebelli, or the foramen magnum - compressing structures on the way and producing recognisable clinical syndromes.

Clinical examination

• Glasgow Coma Scale, recorded serially - a falling trend is more informative than any single value
• Pupils - size, symmetry and reactivity; a unilateral fixed dilated pupil demands immediate action
• Fundoscopy for papilloedema
• Focal neurology, including any false localising signs
• Vital signs - looking specifically for Cushing's triad
• Signs of the underlying cause - fever (infection), trauma, signs of chronic liver disease (hepatic encephalopathy)

Investigations

• Urgent CT head - the key investigation, identifying the cause (haemorrhage, mass, hydrocephalus) and showing indirect signs of raised ICP: effacement of the sulci and basal cisterns, midline shift, and loss of grey-white differentiation
• MRI - more sensitive for tumour, abscess and some causes of oedema, but rarely the first test in an emergency because of speed and access
• Invasive ICP monitoring - an intraparenchymal or intraventricular device, used in intensive care to guide treatment in traumatic brain injury and other settings where trends matter more than a single reading³
• Blood tests - looking for a metabolic contributor (ammonia in suspected hepatic encephalopathy, glucose, sodium)

Management

General measures

• Head-up tilt to 30 degrees and a neutral neck position - promotes venous drainage and lowers ICP
• Maintain normal oxygenation and normocapnia - both hypoxia and hypercapnia cause cerebral vasodilatation and worsen ICP; controlled ventilation is used in intubated patients to keep PaCO2 in the low-normal range
• Maintain adequate cerebral perfusion pressure (mean arterial pressure minus ICP) - avoiding both hypotension (which drops perfusion) and severe hypertension
• Analgesia and sedation as needed, avoiding agitation and coughing/straining which transiently raise ICP
• Treat seizures promptly, since they increase cerebral metabolic demand and ICP
• Normothermia - fever increases cerebral metabolic rate and worsens outcomes

Medical treatment of acutely raised ICP

• Mannitol - an osmotic diuretic that draws free water out of brain tissue across an intact blood-brain barrier, given as a bolus for acute deterioration; requires monitoring of serum osmolality and renal function
• Hypertonic saline - an alternative osmotic agent, also expands intravascular volume, useful where mannitol is contraindicated (for example, hypovolaemia)
• Dexamethasone - effective specifically for vasogenic oedema around a tumour or abscess, but of no proven benefit (and potential harm) in traumatic brain injury or stroke-related oedema - an important and frequently tested distinction
• Therapeutic hyperventilation - lowers ICP rapidly by inducing cerebral vasoconstriction, but only as a short-term bridging measure, since sustained hyperventilation risks cerebral ischaemia from excessive vasoconstriction

Definitive and surgical treatment

• Treat the underlying cause - evacuate a haematoma, resect a tumour or abscess, treat infection, anticoagulate for venous sinus thrombosis
• CSF diversion - external ventricular drain for acute obstructive hydrocephalus, or a ventriculoperitoneal shunt for chronic hydrocephalus
• Decompressive craniectomy - removal of a section of skull to allow the swollen brain to expand outward rather than compress itself, used in refractory raised ICP from large ischaemic stroke ('malignant MCA syndrome') or severe traumatic brain injury when medical measures fail

Complications

• Herniation and brainstem death
• Secondary ischaemic injury from reduced cerebral perfusion pressure
• Permanent visual loss from chronic papilloedema
• Diabetes insipidus or SIADH from hypothalamic-pituitary involvement in severe cases
• Complications of treatment - electrolyte disturbance from osmotic therapy, infection from invasive monitoring or CSF diversion devices

Red flags

The central principle is that the classic signs of raised intracranial pressure appear late. Waiting for the full picture before acting means intervening after herniation has begun, which is why the earlier and subtler features below carry as much weight as the dramatic ones.

Prognosis

Outcome depends entirely on the underlying cause, how rapidly raised ICP develops, and how promptly it is recognised and treated. Slowly evolving causes (a growing tumour) allow more compensation and later presentation, whereas rapidly evolving causes (extradural haemorrhage, acute hydrocephalus) can progress to herniation within hours. Early recognition - before Cushing's triad or a fixed pupil develop - and prompt treatment of both the pressure itself and its underlying cause are the strongest determinants of a good outcome.

A final practical point concerns monitoring. In an unsedated patient, serial GCS and pupillary assessment remain the most sensitive indicators of deterioration, which is why frequent, structured neurological observations are prescribed rather than left to discretion. Once a patient is sedated and ventilated, those clinical signs are lost, and this is precisely the situation in which invasive intracranial pressure monitoring earns its place - allowing treatment to be titrated to measured pressure and cerebral perfusion pressure rather than to signs that sedation has abolished.